LMND (NYSE: LMND) holder plans 7,919-share sale and discloses prior trades

Rhea-AI Filing Summary

LMND shareholder Adina Eckstein filed a notice to sell 7,919 shares of common stock through broker Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of 626,947.00. The filing reports that 74,731,027 shares of this class were outstanding. The shares to be sold relate to common stock, and the form confirms the filer’s representation that they are unaware of any undisclosed material adverse information about the issuer.

The notice also details that Eckstein previously acquired 56,252 common shares on 02/07/2023 via an RSU transaction with the issuer. Over the past three months, she sold multiple blocks of common shares, including 40,000 shares on 11/07/2025 and 41,557 shares on 12/08/2025, generating significant gross proceeds. This document outlines planned and recent sales rather than changes to the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	7919	626947.00	74731027	12/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/07/2023	RSU	Issuer			56252	02/07/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adina Eckstein 5 Crosby Street 3rd Floor New York NY 10013	Common	11/07/2025	40000	2920868.00
Adina Eckstein 5 Crosby Street 3rd Floor New York NY 10013	Common	11/17/2025	5988	467064.00
Adina Eckstein 5 Crosby Street 3rd Floor New York NY 10013	Common	12/08/2025	41557	3280672.13
Adina Eckstein 5 Crosby Street 3rd Floor New York NY 10013	Common	12/09/2025	29237	2256219.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the LMND Form 144 filing disclose about upcoming share sales?

The Form 144 notice states that 7,919 common shares of LMND are planned to be sold through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of 626,947.00.

How many LMND shares are reported as outstanding in this Form 144?

The filing reports that the number of shares outstanding for the relevant class of LMND common stock is 74,731,027.

Who is the selling shareholder in the LMND Form 144 and what did they previously sell?

The selling shareholder is Adina Eckstein, who, over the past three months, sold several blocks of LMND common stock, including 40,000 shares on 11/07/2025 and 41,557 shares on 12/08/2025, with disclosed gross proceeds for each transaction.

How were the LMND shares planned for sale originally acquired?

The filing shows that 56,252 common shares were acquired on 02/07/2023 via an RSU transaction from the issuer, with the payment date also listed as 02/07/2023 and the nature of payment recorded as N/A.

What representations does the Form 144 seller make about LMND in this notice?

By signing the notice, the seller represents that they do not know any material adverse information about LMND’s current or prospective operations that has not been publicly disclosed.

Does the LMND Form 144 mention Rule 10b5-1 trading plans?

Yes. The form allows the seller to indicate a date of plan adoption or instruction if they are relying on Rule 10b5-1, and reiterates that the seller makes the same representation as of that plan or instruction date.